ApprovalTrail

Drug · DIN 02477955

OLIMEL 7.6% E

Yes: authorized and sold in Canada

Authorized, and the company reports that it sells it in Canada.

Status Marketed since October 25, 2018; first marketed October 25, 2018.
Drug Identification Number (DIN)
02477955
Company (DIN owner)
Baxter CorporationMississauga, Ontario, Canada
Schedule
Ethical
Dosage form
Emulsion
Route
Intravenous
Therapeutic class (ATC)
Combinations B05BA10
Class
Human
Record last updated
March 22, 2025

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
OLIVE OIL28 GL
SOYBEAN OIL7 GL
ALANINE10.99 GL
L-ARGININE7.44 GL
L-ASPARTIC ACID2.2 GL
GLUTAMIC ACID3.79 GL
GLYCINE5.26 GL
HISTIDINE4.53 GL
L-ISOLEUCINE3.79 GL
L-LEUCINE5.26 GL
LYSINE (L-LYSINE ACETATE)5.97 GL
METHIONINE3.79 GL
L-PHENYLALANINE5.26 GL
L-PROLINE4.53 GL
SERINE3 GL
L-THREONINE3.79 GL
TRYPTOPHAN1.26 GL
L-TYROSINE0.2 GL
L-VALINE4.86 GL
SODIUM ACETATE TRIHYDRATE1.5 GL
SODIUM GLYCEROPHOSPHATE3.67 GL
POTASSIUM CHLORIDE2.24 GL
MAGNESIUM CHLORIDE0.81 GL
CALCIUM CHLORIDE0.52 GL
DEXTROSE80.67 GL

Notices of Compliance

Health Canada approvals that name this DIN.

  • June 26, 2018: NOC 21021Supplement to a New Drug Submission (SNDS) · To add a new 7.6% and 7.6% e (with electrolytes) strengths to the olimel product line